Building long-term value through strategy and partnership.

Signal Path

Raleigh, North Carolina, USA

Investment Date:
April 2015

Exit Date:
August 2021



Signal Path enhances clinical research by dramatically improving the ease and efficiency of trial execution and management by combining a network of premier, technology-enabled research sites with a best-in-class suite of clinical trial tools to reduce complexity experienced by sites and sponsors.  The company’s clinical trial management system (CTMS) digitizes protocols for clients, which eliminates a significant impediment to utilization, ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.

www.signalpath.com

 

© 2021 Highlander Partners